COMMUNIQUÉS West-GlobeNewswire
-
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
26/03/2024 - 13:30 -
PharmAla Biotech Signs Sale Agreement with Numinus
26/03/2024 - 13:55 -
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
26/03/2024 - 14:00 -
Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Employers for 2024
26/03/2024 - 14:00 -
American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO
26/03/2024 - 14:00 -
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26/03/2024 - 14:00 -
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
26/03/2024 - 14:00 -
Save the date for ALK’s Capital Markets Day on 4 June 2024
26/03/2024 - 14:00 -
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
26/03/2024 - 14:05 -
Les scientifiques de l’hôpital spécialisé et centre de recherche King Faisal contribuent aux efforts internationaux de lutte contre l’antibiorésistance des bactéries en identifiant une toute nouvelle espèce de bactérie : Riyadhensis
26/03/2024 - 14:10 -
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
26/03/2024 - 14:15 -
Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
26/03/2024 - 14:15 -
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
26/03/2024 - 14:22 -
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
26/03/2024 - 14:28 -
Hapbee Announces Closing of Private Placement
26/03/2024 - 14:30 -
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
26/03/2024 - 10:00 -
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
26/03/2024 - 11:00 -
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
26/03/2024 - 11:30 -
CARBIOS rejoint Paris Good Fashion pour accélérer la circularité des textiles et contribuer à une mode plus durable
26/03/2024 - 06:45
Pages